Oscar Health (NYSE:OSCR) Posts Quarterly Earnings Results, Beats Estimates By $0.96 EPS

Oscar Health (NYSE:OSCR) released its earnings results on Wednesday. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96, FiscalAI reports. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter last year, the firm earned $0.92 EPS. The firm’s quarterly revenue was up 52.6% compared to the same quarter last year.

Here are the key takeaways from Oscar Health’s conference call:

• Oscar reported a strong Q1 with $4.6B revenue (+53% YoY), earnings from operations of $704M, net income of $679M and adjusted EBITDA of $727M, and management reaffirmed full‑year 2026 guidance.
• Membership accelerated to 3.2 million (56% YoY), driven by above‑market open enrollment growth and solid retention, supporting scale and revenue upside.
• SG&A efficiency improved to a company‑low 15.2% of revenue, credited to disciplined cost management and expanding AI/tech use cases that management says will further lower per‑member costs.
• Risk adjustment remains a key swing factor: Q1 RA ran ~24% (seasonal/claims dynamics), above the company’s full‑year target of ~20%, and management cautioned RA and market morbidity uncertainty could materially affect 2026 EBITDA until further Wakely/claims data arrive.
• Balance sheet and capital position are strong with $8.1B cash & investments and ~$1.7B statutory surplus (including ~$809M excess), giving flexibility to fund growth and absorb volatility.

Oscar Health Trading Up 11.0%

OSCR traded up $1.98 during trading on Wednesday, hitting $19.92. 18,840,597 shares of the stock traded hands, compared to its average volume of 6,262,071. The firm has a market capitalization of $5.93 billion, a P/E ratio of -11.45 and a beta of 2.34. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96. The firm has a 50-day moving average of $14.26 and a 200 day moving average of $15.28. Oscar Health has a 12-month low of $10.69 and a 12-month high of $23.80.

Key Headlines Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Strong earnings and record profit: Oscar reported GAAP EPS of $2.07, well above consensus, and media outlets highlighted a record quarterly profit (~$679M), which underpins the rally. Oscar Health Reports Record Profit
• Positive Sentiment: Margin improvement / strong adjusted results: Management disclosed sizable Adjusted EBITDA (~$727M) and an improved medical loss ratio, evidence of operating leverage as membership scales — a core bullish thesis. Earnings Review
• Positive Sentiment: Membership and revenue growth: Membership jumped >50% and revenue rose ~52.6% YoY, validating growth strategy and contributing to scale benefits cited on the call. MarketBeat Earnings Summary
• Neutral Sentiment: Conference call / transcripts available: Management reaffirmed guidance and discussed product mix, tech leverage and membership trends — read the full call for detail if you trade intraday. Earnings Call Transcript
• Negative Sentiment: Revenue missed Street estimates: Q1 revenue was $4.65B versus ~ $4.90B expected, which is a potential warning if top-line momentum or pricing mix weakens. Revenue Miss Coverage
• Negative Sentiment: Mixed metrics & accounting nuance: Some summaries cite remaining negative GAAP ratios (net margin/ROE) and differences between GAAP vs. adjusted results — risks for investors who focus on one metric set or prefer consistent top-line beats. Market Data & Ratios

Analyst Ratings Changes

Several equities analysts recently commented on OSCR shares. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. UBS Group reaffirmed a “neutral” rating and set a $15.00 target price on shares of Oscar Health in a report on Wednesday, February 11th. Wolfe Research started coverage on shares of Oscar Health in a report on Tuesday. They set a “peer perform” rating on the stock. Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their target price for the company from $10.00 to $16.00 in a report on Monday, April 20th. Finally, Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a report on Thursday, February 12th. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $16.78.

Insiders Place Their Bets

In other news, CEO Mark T. Bertolini purchased 1,000,000 shares of the company’s stock in a transaction on Monday, April 6th. The stock was acquired at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the transaction, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at approximately $121,546,761.92. This represents a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Institutional investors have recently added to or reduced their stakes in the company. Strs Ohio purchased a new stake in Oscar Health during the 1st quarter valued at $30,000. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the period. Quarry LP boosted its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares during the period. Binnacle Investments Inc purchased a new stake in Oscar Health during the 2nd quarter valued at $75,000. Finally, National Bank of Canada FI purchased a new stake in Oscar Health during the 3rd quarter valued at $81,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.